首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1629829

全球便携式製氧机市场 - 2024-2031

Global Portable Oxygen Concentrators Market - 2024-2031

出版日期: 2024年12月30日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2023年，全球便携式製氧机市场规模达到20.9亿美元，预计2031年将达到50.6亿美元，2024-2031年预测期间复合年增长率为11.8%。

便携式製氧机 (POC) 是一种紧凑、轻巧的设备，可为外出时有呼吸需求的个人提供补充氧气。这些机器吸入周围空气，对其进行过滤，并透过鼻插管或面罩输送浓缩氧气。 POC 通常使用电池电源、交流电或直流电，这使得它们能够适应各种环境，包括旅行。

便携式製氧机主要透过脉衝剂量系统输送氧气，每次吸入时都会大量释放氧气，儘管有些型号也提供连续流量选项。航空公司越来越接受 POC 在飞行中使用，这进一步提高了其在旅行期间需要氧气治疗的用户中的受欢迎程度。

市场动态：

驱动程式和限制

便携式製氧机的采用率不断上升

便携式製氧机 (POC) 市场正在经历显着成长，这主要是由于这些设备的日益普及所推动的。促成这一趋势的几个关键因素包括技术的进步、患者人数的成长以及不断变化的医疗保健动态。随着全球人口老化，与年龄相关的呼吸系统问题也相应增加。老年人特别容易患慢性阻塞性肺病（COPD）和其他慢性肺部疾病，这些疾病通常需要长期氧气治疗。例如，美国疾病管制与预防中心表示，2021年，超过1500万美国人（6.4%）报告他们被诊断出患有慢性阻塞性肺病。

老年患者更有可能需要氧气治疗，他们更喜欢便携式解决方案，使他们能够维持日常活动和积极的生活方式。例如，根据美国国立卫生研究院2024年的数据，美国每年约有150万名患者接受长期氧气治疗。这种人口结构的变化极大地增加了对 POC 的需求。许多需要长期氧气治疗的人更喜欢家用便携式浓缩器，而不是固定係统或气瓶。 POC 允许用户在家中保持移动性并促进户外活动。

与早期型号相比，现代设备现在更小、更轻且更用户友好。电池技术的创新增强了这些集中器的便携性，从而延长了电池寿命并提高了使用过程中的舒适度，使它们对患者更具吸引力。

有限的氧气流量

便携式製氧机（POC）市场正在稳步成长，主要是由于慢性阻塞性肺病（COPD）、气喘等呼吸系统疾病的盛行率不断上升以及人口老化。然而，由于许多设备提供的氧气流量有限，市场面临挑战。

便携式製氧机通常提供 1 至 3 公升/分钟 (LPM) 之间的氧气流量以实现连续流动，对于脉衝流量设定可提供更高的流量。然而，患有更严重呼吸系统疾病的患者可能需要更高的流速，例如 5 LPM 或更高。这项限制限制了许多 POC 对患有晚期 COPD 或其他严重呼吸道疾病的个体的可用性，从而缩小了製造商的目标市场。因此，上述因素可能会阻碍市场的成长。

Portable Oxygen Concentrators (POCs) are compact, lightweight devices that provide supplemental oxygen to individuals with respiratory needs while away from home. These machines draw in ambient air, filter it, and deliver concentrated oxygen through a nasal cannula or mask. POCs typically utilize battery power, AC electricity, or DC power, making them versatile for various settings, including travel.

Portable oxygen concentrators deliver oxygen primarily through pulse dose systems, releasing oxygen in bursts with each inhalation, although some models also offer continuous flow options. The growing acceptance of POCs by airlines for in-flight use has further enhanced their popularity among users who require oxygen therapy during travel.

Market Dynamics: Drivers & Restraints

Rising adoption of portable oxygen concentrators

The portable oxygen concentrators (POCs) market is experiencing significant growth, largely driven by the increasing adoption of these devices. Several key factors contribute to this trend, including advancements in technology, a growing patient population, and evolving healthcare dynamics. As the global population ages, there is a corresponding rise in age-related respiratory issues. Older adults are particularly vulnerable to conditions like chronic obstructive pulmonary disease (COPD) and other chronic lung diseases, which often necessitate long-term oxygen therapy. For instance, the Centers for Disease Control and Prevention stated that in 2021, more than 15 million Americans (6.4%) reported that they had been diagnosed with COPD.

Elderly patients, who are more likely to require oxygen therapy, prefer portable solutions that enable them to maintain their daily activities and active lifestyles. For instance, according to the National Institute of Health in 2024, each year, approximately 1.5 million patients in the USA receive long-term oxygen therapy. This demographic shift significantly boosts the demand for POCs. Many individuals requiring long-term oxygen therapy favor portable concentrators for home use over stationary systems or cylinders. POCs allow users to maintain mobility within their homes and facilitate outdoor activities.

Modern devices are now smaller, lighter, and more user-friendly compared to earlier models. Innovations in battery technology have enhanced the portability of these concentrators, resulting in longer battery life and improved comfort during use, making them more appealing to patients.

Limited oxygen flowrates

The portable oxygen concentrators (POCs) market is experiencing steady growth, primarily driven by the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and the aging population. However, the market faces challenges due to the limited oxygen flow rates offered by many devices.

Portable oxygen concentrators generally provide oxygen flow rates between 1 to 3 liters per minute (LPM) for continuous flow, with higher rates available for pulse flow settings. However, patients with more severe respiratory conditions may require higher flow rates, such as 5 LPM or more. This limitation restricts the usability of many POCs for individuals with advanced-stage COPD or other serious respiratory diseases, thereby narrowing the target market for manufacturers. Thus, the above factors could hinder the market growth.

Segment Analysis

The global Portable Oxygen Concentrators market is segmented based on product type, application, end-user and region.

Product Type:

Continuous flow oxygen concentrators segment is expected to dominate the portable oxygen concentrators market share

The continuous flow oxygen concentrators segment is expected to dominate the portable oxygen concentrators market. Continuous flow concentrators are particularly advantageous for patients with severe respiratory conditions, as they provide a steady supply of oxygen without the need for breath detection technology, making them more reliable for those requiring higher flow rates.

Additionally, advancements in technology have improved the efficiency and reliability of these devices, enhancing their appeal in both home healthcare settings and medical facilities. The cost-effectiveness of continuous flow concentrators, which tend to be cheaper than pulse flow models due to their simpler design, also contributes to their growing market dominance. For instance, the range of continuous flow portable oxygen concentrators begins from Philips SimplyGo, costing around ₹ 1.80 Lakh, to the top-end SeQual Eclipse, costing around ₹ 3.20 Lakh. This makes the consumers feel convenient over the other types.

Geographical Analysis

North America is expected to hold a significant position in the portable oxygen concentrators market share

North America holds a major portion of the portable oxygen concentrators market and is expected to hold a significant position in the portable oxygen concentrators market. This is due to the growing adoption of portable oxygen concentrators, the increasing number of product launches, and the rising prevalence of respiratory diseases.

The region is experiencing high rates of respiratory diseases such as asthma and COPD among others which increases the need for oxygen therapy. Increasing these conditions in the region increases the demand for these devices. For instance, according to the Asthma and Allergy Foundation of America, nearly 28 million people in the U.S. have asthma. This equals about 1 in 12 people. Nearly 23 million U.S. adults ages 18 and older have asthma. Asthma rates are highest in Black adults in the U.S.

The presence of a large number of key players in the region is also contributing to the growth of the region's market. Companies are introducing the latest portable oxygen concentrators in the region. For instance, in October 2024, Inogen, Inc. announced that it had commenced the U.S. market release of the Inogen Rove 4 Portable Oxygen Concentrator. With an additional, fourth flow setting delivering up to 840ml/min of medical grade oxygen, in a lightweight user-friendly design of less than 3 lbs1 and three battery configurations providing up to 5 hours and 45 minutes of operation2, the versatility of Rove 4 empowers patients with choices that may help them with normal activities of daily living.

Thus, rising technological advancements, increasing adoption and rising number of launches of the products in the region are expected to drive the region's market growth.

Asia-Pacific is growing at the fastest growing pace in the portable oxygen concentrators market

Asia-Pacific is at the fastest growing pace in portable oxygen concentrators. This is due to the rising number of launches of advanced oxygen concentrators and rising technological advancements in the region. There is a growing number of respiratory diseases among individuals in the region who are receiving oxygen therapies which is raising the demand for portable oxygen concentrators which makes the individuals carry them easily.

There is a growing adoption of portable oxygen concentrators among individuals in the region. With the rising number of Asthma patients, the need for these devices is rising. For instance, according to the report by the Global Asthma Network in 2022, among India's 1.36 billion people, about 35 million suffer from asthma.

Competitive Landscape

The major global players in the portable oxygen concentrators market include Inogen, Inc., Koninklijke Philips N.V., Pure O2 Ltd, Belluscura, BPL Medical Technologies, GCE Group, Timago, CAIRE Inc., ResMed, and Invacare Corporation among others.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Global portable oxygen concentrators market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Application
3.3. Snippet by End-User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising adoption of portable oxygen concentrators
- 4.1.2. Restraints
  - 4.1.2.1. Limited oxygen flowrates
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 6.1.2. Market Attractiveness Index, By Type
6.2. Continuous Flow*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Pulse Dose

7. By Application

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 7.1.2. Market Attractiveness Index, By Application
7.2. Asthma*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. COPD
7.4. Respiratory Distress Syndrome
7.5. Others

8. By End-User

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 8.1.2. Market Attractiveness Index, By End-User
8.2. Homecare*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Travelers
8.4. Hospitals
8.5. Ambulatory Surgical Centers
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. The U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Inogen, Inc.*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Koninklijke Philips N.V.
11.3. Pure O2 Ltd
11.4. Belluscura
11.5. BPL Medical Technologies
11.6. GCE Group
11.7. Timago
11.8. CAIRE Inc.
11.9. ResMed
11.10. Invacare Corporation

LIST NOT EXHAUSTIVE